Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-19
2006-09-19
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
34, 34
Reexamination Certificate
active
07109339
ABSTRACT:
The present invention is directed to novel compounds represented by structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein R1, R4a, R5, R6, R7, R8, R9,and m, are defined herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain central nervous system disorders. The compounds of this invention are serotonin receptor modulators, in particular 5HT2Creceptor agonists and antagonists, and are useful in the control or prevention of central nervous system disorders including obesity, anorexia, bulemia, depression, anxiety, psychosis, schizophrenia, migraine, addictive behavior, obsessive-compulsive disorder, and sexual disorders.
REFERENCES:
patent: 3914421 (1975-10-01), Rajagopalan
patent: 4013652 (1977-03-01), Rajagopalan
patent: 4115577 (1978-09-01), Rajagopalan
patent: 4183936 (1980-01-01), Rajagopalan
patent: 4219550 (1980-08-01), Rajagopalan
patent: 4238607 (1980-12-01), Rajagopalan
patent: 6057325 (2000-05-01), Kennis et al.
patent: 6548493 (2003-04-01), Robichaud et al.
patent: 6552017 (2003-04-01), Robichaud et al.
patent: 6849640 (2005-02-01), Ennis et al.
patent: 0 473 550 (1992-03-01), None
patent: WO 00/35922 (2000-06-01), None
patent: WO 00/77001 (2000-12-01), None
patent: WO 00/77002 (2000-12-01), None
patent: WO 00/77010 (2000-12-01), None
patent: WO 02/059129 (2002-08-01), None
patent: WO 03/014118 (2003-02-01), None
Chojnacka-Wó´jcik, E. et al., “Involvement of 5-HT2CReceptors in the m-CPP-Induced Antinociception in Mice”, Pol. J. Pharmacol., vol. 46, pp. 423-428 (1994).
Cryan, J.F. et al., “Antidepressant-Like Behavorial Effects Mediated by 5-Hydroxytrepamine2CReceptors”, The Journal of Pharmacology and Experimental Therapeutics, vol. 295, No. 3, pp. 1120-1126 (2000).
Grottick, A.J. et al., “Activation of 5-HT2Creceptors reduces the locomotor and rewarding effects of nicotine”, Psychopharmacology, vol. 157, pp. 292-298 (2001).
Grottick, A.J. et al., “Studies to Investigate the Role of 5-HT2CReceptors on Cocaine- and Food- Maintained Behavior”, The Journal of Pharmacology and Experimental Therapeutics, vol. 293, No. 3, pp. 1183-1191 (200).
Hoffman, B.J. et al., “Distribution of serotonin 5-HT1Creceptor mRNA in adult rat brain”, FEBS Letters, vol. 247, No. 2, pp. 453-462 (1989).
Hoyer, D. et al., “VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin)”, Pharmacological Reviews, vol. 46, No. 2, pp. 157-203 (1994).
Kinbara, K. et al., “Chiral discrimination upon crystallization of the disastereomeric salts of 1- arylethylamines with mandelic acid orp- methoxymandelic acid: interpretation of the resolution efficiencies on the basis of the crystal structures”, J. Chem. Soc., Perkin Trans. 2, pp. 2615-2622 (1996).
Mazzola-Pomietto, P. et al., “Evidance thatm- chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2Creceptors”, Psychopharmacology, vol. 123, pp. 333-339 (1996).
Millan, M.J. et al., “5-HT2Creceptors mediate penile erections in rats: actions of novel and selective agonists and antagonists”, European Journal of Pharmacology, vol. 325, pp. 9-12 (1997).
Nonogaki, K. et al., “Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2Creceptor gene”, Nature Medicine, vol. 4, No. 10, pp. 1152-1156 (1998).
Rittenhouse, P.A. et al., “Evidence that ACTH Secretion Is Regulated by Serotonin2A/2C(5-HT2A/2C) Receptors”, The Journal of Pharmacology and Experimental Therapeutics, vol. 271, No. 3, pp. 1647-1655 (1994).
Sharpley, A.L. et al., “Slow Wave Sleep in Humans: Role of 5-HT2Aand 5-HT2CReceptors”, Neuropharmacology, vol. 33, No. 3/4, pp. 467-471 (1994).
Sundberg, R.J., Indoles, Academic Press Limited, publ., p. v (table of contents) (1996).
Tomori, H. et al., “Facile Optical Resolution of a Dibenzopyrazinoazepine Derivative and the Nature of Molecular Recognition of Amines by Chiral 2,3-Di-O-(arylcarbonyl)tartaric Acids”, Bull. Chem. Soc. Jpn., vol. 69, No. 12, pp. 3581-3590 (1996).
Vickers, S.P. et al., “Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats”, British Journal of Pharmacology, vol. 130, pp. 1305-1314 (2000).
Vickers, S.P. et al., “Evidence that hypophagia induced by d-fenfluramine and d-nonfenfluramine in the rat is mediated by 5-HT2Creceptors”, Neuropharmacology, vol. 41, pp. 200-209 (2001).
Vickers, S.P. et al., “Reduced satiating effect ofd-fenlurnmine in serotonin 5-HT2Creceptor mutant mice”, Psychopharmacology, vol. 143, pp. 309-314 (1999).
DiMatteo, V., et al., “Role of 5-HT2Creceptors in the control of central dopamine function”, Trends in Pharmacological Sciences, vol. 22, No. 5, pp. 229-232, May 2001.
Database Caplus on STN, AN 1989:497120, Marko et al. “Synthesis of tritium-labeled stobadin, a new cardioprotective agent”, abstract, Journal of Labeled Compounds and Radiopharmaceuticals, 1989, 27(1), 35-43.
Database Caplus on STN, AN 1975:508140, Barkov et al. “Relation between the chemical structure and pharmacological activity of carboline derivatives”, abstract, Khimiko-Farmatsevticheskii Zhurnal (1975), 9(4), 6-10.
Chen Wenting
Deng Wei
Lee Taekyu
Robichaud Albert J.
Wexler Ruth R.
Bristol--Myers Squibb Company
Duncan, Jr. Sammy G.
Seaman D. Margaret
LandOfFree
Substituted tricyclic gamma-carbolines as serotonin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tricyclic gamma-carbolines as serotonin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tricyclic gamma-carbolines as serotonin receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3564820